Bernstein Raises Lam Research Price Target to $275
- Rating
- Outperform
- Target
- $275
- from $225 (+22%)
- Outcome
- Reached
- on May 5, 2026
Bernstein’s latest target on Lam Research is now $350 (Oct 22, 2026); the median of 9 firms is $350. Bernstein has reached 81% of its year-old targets (37 scored).

What the analyst said
Bernstein SocGen Group analyst Stacy Rasgon raised the price target on Lam Research (NASDAQ: LRCX) to $275.00 (from $225.00) while maintaining an Outperform rating.
“Investors have been going gaga for semicap lately, an appetite that appears to be well warranted; in fact it seems likely that Lam will hit their CY2028 analyst day model in FISCAL 2027 or even earlier (i.e. at least18 months ahead of schedule).
And given much of the cleanroom space getting will take time to hit, it seems likely that this cycle could continue for quite a while. As it does, the company appears well-positioned to benefit as spending levels move higher, with favorable exposure to key inflections (GAA, packaging, HBM, NAND upgrades and, eventually, greenfield additions) amid really solid internal execution.
Valuation remains rich of course, but we think you still want to be here. Raising estimates, multiple to 40x (vs 35x prior) given industry potential; PT to $275 (40x on avg FY27/28 EPS). We rate LRCX Outperform.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
LRCX trades at $183. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $275 target is 21% below the median, the lowest on the Street.
Since the note LRCX has moved −24% (from $240). 12-month window: day 295 of 365, closes on January 29, 2027.
Track record
This call✓ Target reached on May 5, 2026, 3 months after the note.
Firm track recordBernstein: 81% of its 37 targets at least a year old were reached within 12 months (#9 of 29 firms). Accuracy ranking →
Bernstein on Lam Research
Bernstein price targets on Lam Research
6 calls from January 12, 2026 to October 22, 2026. The target went from $225 to $350 (+56%). The rating stayed Buy.
- October 22, 2026Target cut from $385 (−9%)Buy$350
- August 10, 2026Target raised from $340 (+13%)Buy$385
- May 20, 2026Target raised from $285 (+19%)Buy$340
- February 9, 2026Target raised from $275 (+4%)Buy$285
- January 29, 2026 This noteTarget raised from $225 (+22%)Buy$275
- January 12, 2026Earliest call shownBuy$225



